Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.

Oehme F, Krahl S, Gyorffy B, Muessle B, Rao V, Greif H, Ziegler N, Lin K, Thepkaysone ML, Polster H, Tonn T, Schneider M, Weitz J, Baenke F, Kahlert C.

RNA Biol. 2019 Oct;16(10):1339-1345. doi: 10.1080/15476286.2019.1637697. Epub 2019 Jul 7.

PMID:
31251124
2.

Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes.

Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C.

J Clin Med. 2019 May 16;8(5). pii: E696. doi: 10.3390/jcm8050696.

3.

Lack of beta-arrestin signaling in the absence of active G proteins.

Grundmann M, Merten N, Malfacini D, Inoue A, Preis P, Simon K, Rüttiger N, Ziegler N, Benkel T, Schmitt NK, Ishida S, Müller I, Reher R, Kawakami K, Inoue A, Rick U, Kühl T, Imhof D, Aoki J, König GM, Hoffmann C, Gomeza J, Wess J, Kostenis E.

Nat Commun. 2018 Jan 23;9(1):341. doi: 10.1038/s41467-017-02661-3.

4.

Letters.

Dunning-Riley S, Johnson T, Gieswein R, Luecke H, Rodden J, Cesare J, Ziegler N, Visco F.

Nursing. 2017 Sep;47(9):8. doi: 10.1097/01.NURSE.0000522013.21267.57. No abstract available.

PMID:
28834924
5.

A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of Actamax™ Adhesion Barrier.

Trew GH, Pistofidis GA, Brucker SY, Krämer B, Ziegler NM, Korell M, Ritter H, McConnachie A, Ford I, Crowe AM, Estridge TD, Diamond MP, De Wilde RL.

Arch Gynecol Obstet. 2017 Feb;295(2):383-395. doi: 10.1007/s00404-016-4211-x. Epub 2016 Nov 14.

6.

Evaluation of the HystSim™-virtual reality trainer: an essential additional tool to train hysteroscopic skills outside the operation theater.

Neis F, Brucker S, Henes M, Taran FA, Hoffmann S, Wallwiener M, Schönfisch B, Ziegler N, Larbig A, De Wilde RL.

Surg Endosc. 2016 Nov;30(11):4954-4961. Epub 2016 Mar 9.

PMID:
26961345
7.

Uterine perforation following a fractional curettage successfully treated with the modified polysaccharide 4DryField® PH: a case report.

Ziegler N, Korell M, Herrmann A, de Wilde MS, Torres-de la Roche LA, Larbig A, De Wilde RL.

J Med Case Rep. 2016 Sep 6;10(1):243. doi: 10.1186/s13256-016-1029-x.

8.

β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.

Ziegler N, Awwad K, Fisslthaler B, Reis M, Devraj K, Corada M, Minardi SP, Dejana E, Plate KH, Fleming I, Liebner S.

J Neurosci. 2016 Aug 24;36(34):8921-35. doi: 10.1523/JNEUROSCI.0148-16.2016.

9.

Long term follow-up concerning safety and efficacy of novel adhesion prophylactic agent for laparoscopic myomectomy in the prospective randomized ADBEE study.

Cezar C, Tchartchian G, Korell M, Ziegler N, Senshu K, De Wilde MS, Herrmann A, Larbig A, De Wilde RL.

Best Pract Res Clin Obstet Gynaecol. 2016 Aug;35:97-112. doi: 10.1016/j.bpobgyn.2016.06.003. Epub 2016 Jul 6.

10.
11.

How to avoid risks for patients in minimal-access trials: Avoiding complications in clinical first-in-human studies by example of the ADBEE study.

Cezar C, Korell M, Tchartchian G, Ziegler N, Senshu K, Herrmann A, Larbig A, De Wilde RL.

Best Pract Res Clin Obstet Gynaecol. 2016 Aug;35:84-96. doi: 10.1016/j.bpobgyn.2015.11.004. Epub 2015 Nov 14.

12.

β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma.

Zinke J, Schneider FT, Harter PN, Thom S, Ziegler N, Toftgård R, Plate KH, Liebner S.

Mol Cancer. 2015 Feb 3;14:17. doi: 10.1186/s12943-015-0294-4.

13.

Analysis of angiogenesis in the developing mouse central nervous system.

Ziegler N, Plate KH, Liebner S.

Methods Mol Biol. 2014;1135:55-68. doi: 10.1007/978-1-4939-0320-7_5.

PMID:
24510854
14.

Sulfated glycosaminoglycans support osteoblast functions and concurrently suppress osteoclasts.

Salbach-Hirsch J, Ziegler N, Thiele S, Moeller S, Schnabelrauch M, Hintze V, Scharnweber D, Rauner M, Hofbauer LC.

J Cell Biochem. 2014 Jun;115(6):1101-11. doi: 10.1002/jcb.24750.

PMID:
24356935
15.

The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells.

Artus C, Glacial F, Ganeshamoorthy K, Ziegler N, Godet M, Guilbert T, Liebner S, Couraud PO.

J Cereb Blood Flow Metab. 2014 Mar;34(3):433-40. doi: 10.1038/jcbfm.2013.213. Epub 2013 Dec 18.

16.

Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.

Reis M, Czupalla CJ, Ziegler N, Devraj K, Zinke J, Seidel S, Heck R, Thom S, Macas J, Bockamp E, Fruttiger M, Taketo MM, Dimmeler S, Plate KH, Liebner S.

J Exp Med. 2012 Aug 27;209(9):1611-27. doi: 10.1084/jem.20111580. Epub 2012 Aug 20.

17.

Selective glucocorticoid receptor modulation maintains bone mineral density in mice.

Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M.

J Bone Miner Res. 2012 Nov;27(11):2242-50. doi: 10.1002/jbmr.1688.

18.

Comparison of the activation kinetics of the M3 acetylcholine receptor and a constitutively active mutant receptor in living cells.

Hoffmann C, Nuber S, Zabel U, Ziegler N, Winkler C, Hein P, Berlot CH, Bünemann M, Lohse MJ.

Mol Pharmacol. 2012 Aug;82(2):236-45. doi: 10.1124/mol.112.077578. Epub 2012 May 7.

PMID:
22564786
19.

Getting the most out of your IP--patent management along its life cycle.

Bader MA, Gassmann O, Ziegler N, Ruether F.

Drug Discov Today. 2012 Apr;17(7-8):281-4. doi: 10.1016/j.drudis.2011.10.025. Epub 2011 Nov 3.

PMID:
22079191
20.

FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.

Ziegler N, Bätz J, Zabel U, Lohse MJ, Hoffmann C.

Bioorg Med Chem. 2011 Feb 1;19(3):1048-54. doi: 10.1016/j.bmc.2010.07.060. Epub 2010 Jul 30.

PMID:
20716489

Supplemental Content

Loading ...
Support Center